Synthesis and in silico evaluation of novel uridyl sulfamoylbenzoate derivatives as potential anticancer agents targeting M1 subunit of human ribonucleotide reductase (hRRM1)
Salvador, Prince J., Jacobs, Heather B., Alnouri, Lujain, Fee, Asia, Utley, Lynn M., Mabry, Madison, Krajeck, Hannah, Dicksion, Christopher, Awad, Ahmed M.
Published in Medicinal chemistry research (01.07.2022)
Published in Medicinal chemistry research (01.07.2022)
Get full text
Journal Article